Although CVS acquiring Aetna has more to do with fending off Amazon than it does diabetes this deal has the potential to change the diabetes management landscape. For years we have been writing about the use of financial incentives to encourage patients to better manage their diabetes. We have argued that attempts at behavior change just don’t work. That patients with diabetes need rewards that are immediate, rewards which impact their lives. Tangible rewards which they can see touch or feel.
Now let’s be very clear here we are in no way implying that patients do not care . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.